Palisade Bio PALI
NASDAQ PALI
$1.13 +0.00 (+0.44%)
As of: Nov 11, 2026 · 3:30 PM EST

Palisade Bio (PALI) Depreciation and Depletion (2023 - 2025)

Updated

Palisade Bio's Depreciation and Depletion came in at $3,000 for FY2025, unchanged from $3,000 in FY2024.

Analysis

Palisade Bio (PALI) Depreciation and Depletion (2023 - 2025) Analysis & Trends

Going back to FY2011, Palisade Bio's Depreciation and Depletion data covers 14 years.

  • Depreciation and Depletion carries a five-year compound annual growth rate of -36.5% (FY2020 to FY2025).
  • The five-year range for annual Depreciation and Depletion is $3,000 (FY2022) to $4,000 (FY2023).
  • Per Business Quant, earlier years put Depreciation and Depletion at $3,000 in FY2024 (-25.0%), $4,000 in FY2023 (+33.3%) and $3,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Palisade Bio 239.59 Mn -265.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 1,000.00
Sep 30, 2024 1,000.00
Jun 30, 2024 1,000.00
Mar 31, 2024 1,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 2,000.00
Mar 31, 2023 1,000.00
API Access

Palisade Bio Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=PALI&period=max&api_key=YOUR_API_KEY